title: Bioresorbable vascular scaffolds in left main coronary artery disease.
abstract: Currently, the use of bioresorbable vascular scaffolds (BRS) for the treatment of left main (LM) coronary artery disease has to be considered investigational. However, some early evidence from case reports supports the feasibility of BRS implantation in selected cases and shows good angiographic and clinical results with current-generation BRS devices. However, before the routine use of BRS for LM disease can be advocated, more data on long-term safety and efficacy and larger scaffold designs are essential.
authors.affiliation: Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: Bert
authors.initials: B
authors.lastname: Everaert
authors.forename: Piera
authors.initials: P
authors.lastname: Capranzano
authors.forename: Corrado
authors.initials: C
authors.lastname: Tamburino
authors.forename: Ashok
authors.initials: A
authors.lastname: Seth
authors.forename: Robert-Jan M
authors.initials: RJ
authors.lastname: van Geuns
mesh_terms: D020341:Absorbable Implants; D003324:Coronary Artery Disease / Q000601:surgery*; D054855:Drug-Eluting Stents; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000295:instrumentation* / Q000379:methods; D011474:Prosthesis Design; D015607:Stents; D054457:Tissue Scaffolds